Patent ID: 11912681
Assignee: MITOBRIDGE, INC.
Field: Organic fine chemistry (Chemistry)
Classification: CPC C  A | IPC C

Claim 8:
9. A method of treating a mitochondrial disease in a subject, comprising administering to the subject in need thereof a therapeutically effective amount of a compound of claim 1, wherein the mitochondrial disease is Alpers Disease, chronic progressive external ophthalmoplegia (CPEO), Kearns-Sayra Syndrome (KSS), Leber Hereditary Optic Neuropathy (LHON), MELAS-mitochondrial myopathy, encephalomyopathy, lactic acidosis, and stroke-like episodes, myoclonic epilepsy with ragged-red fiber disease (MERRF), neurogenic muscle weakness-ataxia-retinitis pigmentosa (NARP), or Pearson Syndrome.